COVID-19 is a severe acute respiratory syndrome that initially infects respiratory epithelial cells by binding to the angiotensin converting enzyme 2 (ACE2) but other cellular targets have been proposed (1, 2, 3, 4, 5). This evidence concerns the gene ACE2 and COVID-19.